Export 35 results:
Autore Titolo Tipo [ Anno] Filtri: Autore è Marcuzzi, Annalisa [Clear All Filters]
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. Curr Pharm Des 2012;18(35):5746-52.
. Serum amyloid A and cholesterol: a pivotal role on inflammation. Amyloid 2012;19(3):163-4; author reply 165-6.
. Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. J Neurovirol 2012;18(5):416-22.
. . Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). Oral Oncol 2011;47(5):436-7; author reply 438.
. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res 2011;70(1):78-82.
. Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In Vivo 2011;25(1):87-92.
. Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. J Korean Med Sci 2011;26(6):848-9; author reply 850.
. Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. Inflamm Res 2010;59(5):335-8.
. Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. Int Immunopharmacol 2010;10(6):639-42.
. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 2010;61(6):506-10.
.